ID

32232

Descripción

Study ID: 106218 Clinical Study ID: TDC106218 Study Title: Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride  Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: testosterone Trade Name: Andropatch,Androderm Study Indication: Hypogonadism, Male

Palabras clave

Versiones (1)
  1. 24/10/18 24/10/18 -
Titular de derechos de autor

GSK group of companies

Subido en

24 de octubre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Bioavailability and Pharmacokinetics of Testosterone with/without Dutasteride - 106218

Inglés

Part 2: Repeat Dose Phase - Day 21 - Treatment confirmation

1 formularios  
Administrative data
Descripción

Administrative data

Subject Identifier
Descripción

Subject Identifier

Tipo de datos

integer

Investigational Product
Descripción

Investigational Product

Planned Timepoint
Descripción

Planned Timepoint

Tipo de datos

integer

Investigational Product
Descripción

Investigational Product

Tipo de datos

text

Date of Dose
Descripción

Date of Dose

Tipo de datos

date

Time of Dose
Descripción

Time of Dose

Tipo de datos

time

Treatment Confirmation
Descripción

Treatment Confirmation

Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?
Descripción

Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?

Tipo de datos

boolean

If NO, record reason(s)
Descripción

If NO, record reason(s)

Tipo de datos

text

Volver a la parte superior de la página

Similar models

Part 2: Repeat Dose Phase - Day 21 - Treatment confirmation

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Subject Identifier
Item
Subject Identifier
integer
Item Group
Investigational Product
Item
Planned Timepoint
integer
Planned Timepoint
Code List
Planned Timepoint
CL Item
Day 20 AM (1)
CL Item
Day 20 AM (2)
CL Item
Day 20 PM (3)
CL Item
Day 20 PM (4)
Item
Investigational Product
text
Investigational Product
Code List
Investigational Product
CL Item
Dustasteride (1)
CL Item
Testosterone (2)
CL Item
Dustasteride (3)
CL Item
Testosterone (4)
Date of Dose
Item
Date of Dose
date
Time of Dose
Item
Time of Dose
time
Item Group
Treatment Confirmation
Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?
Item
Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?
boolean
If NO, record reason(s)
Item
text
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial